Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Darunavir:MCnc:Pt:Ser/Plas:Qn

Known as: Darunavir:Massa concentratie:Moment:Serum of plasma:Kwantitatief, Darunavir [Masse/Volume] Sérum/Plasma ; Numérique, Darunavir:#N/A:Pt:Sor/Plas:Qn 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract The aim of this study is to develop Darunavir (DRV) proliposome powder for oral delivery. Darunavir-loaded oral… Expand
2019
2019
MCC program. Of the remainder, some costs related to protocol and assessment tool development could potentially be minimized by… Expand
2018
2018
Background: Dolutegravir (DTG) plus boosted darunavir (bDRV) is a compact, adherence-friendly salvage regimen with the highest… Expand
2015
2015
HIV-1 samples submitted by clinicians from the United States for routine drug susceptibility testing (PhenoSense GT) were… Expand
2014
2014
High performance liquid chromatographic method was developed and validated for the determination of Darunavir Ethanolate in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 7
2011
2011
Darunavir (TMC 114) is a protease inhibitor used in the therapy of HIV-1. The aim of this study was to formulate 800 mg of… Expand
2010
2010
BACKGROUND Nucleoside-sparing combination antiretroviral therapy (cART) regimens might be an attractive therapeutic option for… Expand
  • table 1
  • table 2
  • figure 1
Highly Cited
2009
Highly Cited
2009
Raltegravir (RAL), maraviroc (MVC), darunavir (DRV), and etravirine (ETV) are new antiretroviral agents with significant… Expand
2009
2009
The influence of ritonavir‐boosted darunavir coadministration on nevirapine pharmacokinetics was investigated in HIV‐infected… Expand